Master Investor 2014 Main Stage Presentations
Terry Smith – How to Play the Emerging Markets
To download the accompanying on-screen presentation please click here
Terry Smith speaking on the Mainstage at Master Investor 2014
Terry Smith is a former number 1 rated analyst, author of bestseller Accounting for Growth, fund manager and FTSE 250 CEO. With a maverick approach and outspoken views on his own industry, he is proving he walks the walk and does not just talk it. Fundsmith was founded in 2010 as the main vehicle for his own investments, but now has over £1.6 billion under management and returned 61% in its first three years. In 2014, Fundsmith will launch an investment trust investing in the same strategy as Fundsmith’s existing equity fund, but in companies that are listed in emerging markets.
Richard Reed – Making Money and Doing Good
To download the accompanying on-screen presentation please click here
Richard Reed speaking on the Mainstage at Master Investor 2014
Richard Reed is a co-founder of Innocent drinks, the UK’s fastest growing food and drinks company and the No.1 smoothie brand in the UK. The business was started in May 1999 by Richard and two friends and now has a turnover of over £150m. Innocent has been called ‘The Ultimate 21st Century Company’ – quirky, personable, values-based and profitable and determined to remain what Reed calls a ‘big small’ company, no matter how large it grows.
As well as growing Innocent, Richard Reed has been a government advisor on entrepreneurship, through round table discussions with the Prime Minister and his seat on the Small Business Council. Richard and Innocent’s awards include E&Y Young Entrepreneur of the Year, National Business Awards’ Small/Medium Business of the Year, Orange Small Business of the Year and Orange Innovative Company of the Year.
Jim Mellon – The Conundrum of Certainties
To download the accompanying on-screen presentation please click here
Jim Mellon speaking on the Mainstage at Master Investor 2014
Jim Mellon is famous for notching up the biggest ever success on the AIM market with Uramin, the company he co-founded in 2005 with $100,000 and sold in 2007
for $2.5 billion. With a substantial international property portfolio and interests in a variety of companies, particularly in the alternative energy and biotech sectors, Jim
is a highly experienced and successful investor whose expert views were closely followed at last year’s Master Investor Show
Evil Kinevil – A year in the life of Evil Knievil
No accompanying presentation was used for this talk
Evil Kinevil speaking on the Mainstage at Master Investor 2014
Evil Knievil, the man the Daily Mail dubbed ‘The King of the Short Sellers’, (otherwise known as Simon Cawkwell) is Britain’s most feared bear-raider. A trained accountant, he made his name exposing the fiction that were Bob Maxwell’s accounts. Evil does not give investment advice but three times a week he provides his thoughts and musings in the “Evil Diaries”
Professor Sir John Bell – The Future of Money & Medicine
To download the accompanying on-screen presentation please click here
Professor Sir John Bell speaking on the Mainstage at Master Investor 2014
Professor Sir John Bell FRS is Regius Professor of Medicine at Oxford University, and Chairman of the Office for the Strategic Coordination of Health Research. He recently stepped down as President of the Academy of Medical Sciences (2006- 2011). As a Rhodes Scholar (1975-78), Sir John undertook his medical training in the UK and then went on to Stanford University, returning to the UK in 1987. His research interests are in the area of autoimmune disease and immunology where he has contributed to the understanding of immune activation in a range of autoimmune diseases. In 1993, he founded the Wellcome Trust Centre for Human Genetics, one of the world’s leading centres for complex trait common disease
genetics. In 2001, he was appointed non-executive director of Roche Holding AG and in 2008 he joined the Gates Foundation Global Health Advisory Board which he has chaired since 2012. Sir John was responsible for the working party that produced the highly influential Academy of Medical Sciences “Strengthening Clinical Research” report that highlighted the need for the UK to focus some of its attention on developing expertise in translational research. In December 2011, Sir John was appointed one of two UK Life Sciences Champions by the Prime Minister.
Paul Kavanagh – Stocks to Sparkle in 2014
To download the accompanying on-screen presentation please click here
Paul Kavanagh speaking on the Mainstage at Master Investor 2014
Paul Kavanagh is a Partner and Senior Market Strategist at Killik & Co, the advisory stockbroker and wealth manager he joined in 1993.
He is also Chairman of Killik Capital, the division of the firm which caters for the more high-risk, sophisticated investor through products including CFDs, Spreadbetting, Managed Futures and Special Situations. Paul is a respected commentator on the markets and the economy, regularly appearing in the financial pages of the weekend press as well as on the BBC’s
‘Today’ programme, ITV’s Daybreak and CNBC. He shares his market thoughts in a podcast released each week.
Master Investor 2015
Attendee Registration for Master Investor 2015 will open shortly.
If you have any questions about attending or exhibiting at Master Investor 2015 please contact info@masterinvestor.co.uk